Delivery Order SPE2DB20D1109-SPE2DB25FN64W

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $22,522.50, is for the delivery of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. This is a firm fixed-price contract with a completion date of January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,661.55, is for the supply of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price and a period of performance through November 13, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,993.96, is for the delivery of the drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 16, 2025 and is a Firm Fixed Price contract. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,735.57, is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order valued at $2,374.92 for the supply of the drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,820.10, is for the supply of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 19, 2024 and is a firm fixed-price contract. AmerisourceBergen is not a small business, and the contract did not have a set-aside designation. This...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,874.78, is a delivery order for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,554.97, is for the delivery of the drug WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract is a firm-fixed-price, non-set-aside award with a completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,046.44 firm fixed-price contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.97 contract is for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a period of performance through February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN64W
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,340.71, is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with a final completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have any set-aside designation, indicating open competition.

Generated 5/30/25, 10:03 AM